Predict your next investment

Viroclinics Biosciences company logo
Corporation
HEALTHCARE | Medical Facilities & Services / Medical Laboratories & Research
viroclinics.eu

See what CB Insights has to offer

Investors Count

3

Viroclinics Biosciences Funding, Viroclinics Biosciences Valuation & Viroclinics Biosciences Revenue

3 Fundings

Viroclinics Biosciences's latest funding round was a Acq - Fin - III for on March 3, 2020.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

3/3/2020

Acq - Fin - III

$0.00B

((9.99x))

FY 1234

1

8/29/2017

Acq - Fin - II

$99M

$0.00B

((9.99x))

FY 1234

10

1/8/2014

Acq - Fin

$99M

$0.00B

((9.99x))

FY 1234

10

Date

3/3/2020

8/29/2017

1/8/2014

Round

Acq - Fin - III

Acq - Fin - II

Acq - Fin

Amount

$99M

$99M

Investors

Valuation

Revenue

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

1

10

10

Viroclinics Biosciences Investors

3 Investors

Viroclinics Biosciences has 3 investors. Summit Partners invested in Viroclinics Biosciences's Acq - Fin - III funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

3/3/2020

3/3/2020

1
Acq - Fin - III

Growth Equity

Massachusetts

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Private Equity

Netherlands

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Venture Capital

Netherlands

First funding

3/3/2020

00/00/0000

00/00/0000

Last Funding

3/3/2020

00/00/0000

00/00/0000

Investor

Subscribe to see more

Subscribe to see more

Rounds

1
Acq - Fin - III

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Subscribe to see more

Type

Growth Equity

Private Equity

Venture Capital

Location

Massachusetts

Netherlands

Netherlands

Viroclinics Biosciences Acquisitions

1 Acquisition

Viroclinics Biosciences acquired 1 company. Their latest acquisition was DDL Diagnostic Laboratory on March 06, 2020.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

3/6/2020

Acquired

1

Date

3/6/2020

Investment Stage

Companies

Valuation

Total Funding

Note

Acquired

Sources

1

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.